株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

加齢性記憶障害:世界の治験動向

Memory Impairment Global Clinical Trials Review, H2, 2017

発行 GlobalData 商品コード 306643
出版日 ページ情報 英文 96 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.48円で換算しております。
Back to Top
加齢性記憶障害:世界の治験動向 Memory Impairment Global Clinical Trials Review, H2, 2017
出版日: 2017年12月28日 ページ情報: 英文 96 Pages
概要

当レポートでは、加齢性記憶障害の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; アジア太平洋地域
    • 主要国における治験件数; 欧州
    • 主要国における治験件数; 北米

G7諸国における治験件数:加齢性記憶障害治験件数の中枢神経系治験件数に対する比率

フェーズ(相)別治験件数:G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:加齢性記憶障害治験件数の中枢神経系治験件数に対する比率

フェーズ(相)別治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別治験件数

有望なスポンサー

治験主要参加企業 - 加齢性記憶障害治療薬

有望な薬剤

治験プロファイルの基本情報

付録

図表

目次
Product Code: GDHC4770CTIDB

GlobalData's clinical trial report, "Memory Impairment Global Clinical Trials Review, H2, 2017" provides an overview of Memory Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Memory Impairment. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Memory Impairment to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Memory Impairment to Central Nervous System Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Memory Impairment Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Latest Clinical Trials News on Memory Impairment 29
  • Nov 06, 2017: Tetra Discovery Partners Research Supports Ability of Novel Selective PDE4D Inhibitor, BPN14770, to Improve Memory and Cognition 29
  • Clinical Trial Profile Snapshots 30

Appendix 94

  • Abbreviations 94
  • Definitions 94
  • Research Methodology 95
  • Secondary Research 95
  • About GlobalData 96
  • Contact Us 96
  • Source 96

List of Tables

List of Tables

  • Memory Impairment Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Memory Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Memory Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Memory Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Memory Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Memory Impairment Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Memory Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Memory Impairment Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Memory Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
  • Memory Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Memory Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Memory Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
  • Memory Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Memory Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Memory Impairment Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Memory Impairment Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Memory Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Memory Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Memory Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Memory Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Memory Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Memory Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Memory Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
Back to Top